Philip Gorelick

[Philip Gorelick @PGorelick]

Start-up biotech companies my play important role in stroke drug development in the future. #isc09

[Philip Gorelick @PGorelick]

Look for future biomarkers of early neurologic deterioration in stroke: MMP-9, endothelin-1, cellular fibronectine. isc#09

[Philip Gorelick @PGorelick]

Excercise and other life-style modifications may help to maintain cognitive vitality.
#isc09

[Philip Gorelick @PGorelick]

Support the NINDS-sponsored WARCEF to assist in completion of recruitment and follow-up. #isc09

[Philip Gorelick @PGorelick]

Cont: Low cardiac output may be associated with cardiac encephalopathy, grey matter loss, focal stroke or TIA. #isc09

[Philip Gorelick @PGorelick]

Cardiac Dysfunction and Stroke Symposium: Heart Failure remains a major cause of cardiac morbidity, mortality and stroke (cont). #isc09

[Philip Gorelick @PGorelick]

#1sc2009: ICH Managment: Does glucose control change outcome? These and other questions below remain unresolved.

[Philip Gorelick @PGorelick]

#isc2009: ICH Management: Does osmotic therapy improve tissue shifts and outcome? (continued)

[Philip Gorelick @PGorelick]

isc2009: ICH management: Does BP control really help?

[Philip Gorelick @PGorelick]

isc2009
Busting Myths of ICH Symposium: Clinical equipoise exists in relation to a number of treatment parameters (cont)

[Philip Gorelick @PGorelick]

#isc2009
Just made it to San Diego.